– the leading provider of online annual reports to individual and institutional investors.

Immunomedics, Inc.

Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports